Quince Therapeutics, Inc. (QNCX)
1.35
-0.01
(-0.74%)
USD |
NASDAQ |
Apr 24, 16:00
1.33
-0.02
(-1.48%)
After-Hours: 20:00
Quince Therapeutics EPS Diluted (Quarterly) : -7.081 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Ocular Therapeutix, Inc. | -0.29 |
| Gossamer Bio, Inc. | -0.2085 |
| Ernexa Therapeutics, Inc. | -0.1923 |
| Acurx Pharmaceuticals, Inc. | -0.6722 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.46M |
| Total Expenses (Quarterly) | 39.46M |
| Enterprise Value | 22.89M |
| Earnings Yield | -989.0% |
| Normalized Earnings Yield | -697.70 |